Ascelia Pharma AB: Biotech Leader Driving New Liver Metastasis & Gastric Cancer Therapies in Sweden
Ascelia Pharma AB is pushing biotech innovation, focusing on liver metastases and gastric cancer treatments in Sweden, while navigating volatile stock and R&D‑heavy growth prospects.
2 minutes to read